<p><h1>Sodium Iodide (131I) for Therapy Market: A Comprehensive Report of its Market Share & Growth Trends 2025 - 2032</h1></p><p><strong>Sodium Iodide (131I) for Therapy Market Analysis and Latest Trends</strong></p>
<p><p>Sodium Iodide (131I) is a radioactive isotope widely utilized in the treatment of thyroid disorders, particularly hyperthyroidism and differentiated thyroid cancer. Its therapeutic applications stem from its ability to selectively target thyroid tissues while minimizing damage to surrounding healthy tissues. Market growth for Sodium Iodide (131I) therapy is driven by the rising prevalence of thyroid-related diseases, advancements in nuclear medicine, and increased awareness regarding early diagnosis and treatment options.</p><p>Recent trends indicate a growing preference for outpatient procedures, as well as the integration of enhanced imaging technologies that improve treatment outcomes. The sodium iodide market is also witnessing innovations in radiopharmaceuticals, ensuring greater efficacy and reduced side effects. Furthermore, aging populations and lifestyle changes leading to thyroid dysfunction are contributing factors to market expansion.</p><p>The Sodium Iodide (131I) for Therapy Market is expected to grow at a CAGR of 4.7% during the forecast period, indicating a healthy demand trajectory. As healthcare providers continuously seek effective solutions for thyroid conditions, Sodium Iodide (131I) remains a central player in the evolving landscape of nuclear medicine therapies.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/2895037?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">https://www.reliableresearchreports.com/enquiry/request-sample/2895037</a></p>
<p>&nbsp;</p>
<p><strong>Sodium Iodide (131I) for Therapy Major Market Players</strong></p>
<p><p>The Sodium Iodide (131I) therapy market has several key players, each contributing to its competitive landscape. Curium Pharma is a prominent player, focusing on nuclear medicine, with significant investments in expanding its radiopharmaceutical portfolio. The company aims to leverage growing thyroid cancer therapies, projecting growth in its sales driven by increased global demand.</p><p>HTA Co., Ltd. is another significant player, emphasizing localized production and distribution of radiopharmaceuticals. Their strategic focus on Asia-Pacific markets aims for revenue growth, facilitated by increasing healthcare infrastructure and rising patient populations.</p><p>Jubilant Pharmova, a global leader, has reported substantial revenues from its radiopharmaceutical segment, attributing growth to expanded distribution and innovative product development. The company's investment in research and development is set to enhance its market share in the Sodium Iodide (131I) segment.</p><p>PDRadiopharma Inc. has carved a niche in North America, capitalizing on regulatory approvals for novel therapies utilizing Sodium Iodide (131I). Its growth strategy includes partnerships and collaborations that broaden its therapeutic applications, aiming to increase market penetration.</p><p>Yantai Dongcheng Pharmaceutical Group, with its robust manufacturing capabilities, is positioned for growth in both domestic and international markets, focusing on the rising demand for radiopharmaceuticals in oncology treatments.</p><p>NTP Radioisotopes and International Isotopes Inc. are also notable players, focusing on reliable supply chains to meet market demands, while ANSTO and POLATOM (NCBJ) provide strategic collaboration in research and clinical applications.</p><p>Overall, the Sodium Iodide (131I) therapy market is anticipated to grow significantly, supported by increasing thyroid disease prevalence and advancements in nuclear medicine, with estimates projecting a market size expansion to several billions in the coming years, driven by the continuous innovation and strategic initiatives of these companies.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Sodium Iodide (131I) for Therapy Manufacturers?</strong></p>
<p><p>The Sodium Iodide (131I) therapy market is poised for significant growth, primarily driven by the rising prevalence of thyroid disorders and the increasing adoption of targeted radiotherapy in oncology. With a market valuation projected to surpass $1 billion by 2028, key growth trends include advancements in nuclear medicine technologies, expanding healthcare infrastructure, and increasing investments in research and development. Moreover, emerging markets are witnessing a surge in demand due to improved healthcare access. Future outlook indicates a focus on personalized medicine and innovations in delivery methods, enhancing treatment efficacy and patient outcomes.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/2895037?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/2895037</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Sodium Iodide (131I) for Therapy Market Analysis by types is segmented into:</strong></p>
<p><ul><li>_capsule</li><li>Solution</li></ul></p>
<p><p>The Sodium Iodide (131I) therapy market comprises two primary types: capsules and solutions. The capsule form offers a convenient oral administration option, making it suitable for outpatient settings where ease of use is essential. In contrast, the solution form is typically administered via injection or infusion, providing precise dosage control for inpatient treatment of conditions like thyroid cancer and hyperthyroidism. Both forms play crucial roles in facilitating effective radiation therapy, catering to different patient needs and clinical scenarios.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/2895037?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">https://www.reliableresearchreports.com/purchase/2895037</a></p>
<p>&nbsp;</p>
<p><strong>The Sodium Iodide (131I) for Therapy Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hyperthyroidism Treatment</li><li>Thyroid Cancer Treatment</li></ul></p>
<p><p>Sodium Iodide (131I) is a radiopharmaceutical used primarily for treating hyperthyroidism and thyroid cancer. In hyperthyroidism, it targets and destroys overactive thyroid tissue, leading to symptom relief and restoring hormonal balance. For thyroid cancer, 131I therapy helps to eliminate residual cancer cells following surgery and reduces the risk of recurrence. The market for Sodium Iodide (131I) therapy is expanding due to increasing thyroid disorders, advancements in nuclear medicine, and growing awareness of its therapeutic benefits.</p></p>
<p><a href="https://www.reliableresearchreports.com/sodium-iodide-131i-for-therapy-r2895037?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">&nbsp;https://www.reliableresearchreports.com/sodium-iodide-131i-for-therapy-r2895037</a></p>
<p><strong>In terms of Region, the Sodium Iodide (131I) for Therapy Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Sodium Iodide (131I) therapy market is poised for significant growth, particularly in North America (30%) and Europe (25%), driven by increasing thyroid disorders and advancements in nuclear medicine. The Asia-Pacific region is expected to expand rapidly, with a projected market share of 20%, due to rising healthcare investments and awareness. China is anticipated to contribute approximately 15%. Together, these regions will shape the competitive landscape, with North America remaining the dominant market, reflecting its robust infrastructure and established healthcare systems.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/2895037?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">https://www.reliableresearchreports.com/purchase/2895037</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/2895037?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">https://www.reliableresearchreports.com/enquiry/request-sample/2895037</a></p>
<p><strong></strong></p>
<p>Check more reports on <a href="https://www.reliableresearchreports.com/?utm_campaign=3070&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=15032025&utm_id=sodium-iodide-131i-for-therapy">https://www.reliableresearchreports.com/</a></p>